These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Sperm DNA fragmentation: paternal effect on early post-implantation embryo development in ART. Borini A; Tarozzi N; Bizzaro D; Bonu MA; Fava L; Flamigni C; Coticchio G Hum Reprod; 2006 Nov; 21(11):2876-81. PubMed ID: 16793992 [TBL] [Abstract][Full Text] [Related]
23. Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology. Eftekhar M; Aflatoonian A; Mohammadian F; Eftekhar T Arch Gynecol Obstet; 2013 May; 287(5):1017-21. PubMed ID: 23208461 [TBL] [Abstract][Full Text] [Related]
24. Oocyte quality in patients with severe ovarian hyperstimulation syndrome: a self-controlled clinical study. Fábregues F; Peñarrubia J; Vidal E; Casals G; Vanrell JA; Balasch J Fertil Steril; 2004 Oct; 82(4):827-33. PubMed ID: 15482755 [TBL] [Abstract][Full Text] [Related]
25. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol. Fatemi HM; Doody K; Griesinger G; Witjes H; Mannaerts B Hum Reprod; 2013 Feb; 28(2):442-52. PubMed ID: 23136144 [TBL] [Abstract][Full Text] [Related]
26. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined? Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979 [TBL] [Abstract][Full Text] [Related]
27. Male age negatively impacts embryo development and reproductive outcome in donor oocyte assisted reproductive technology cycles. Frattarelli JL; Miller KA; Miller BT; Elkind-Hirsch K; Scott RT Fertil Steril; 2008 Jul; 90(1):97-103. PubMed ID: 17765235 [TBL] [Abstract][Full Text] [Related]
28. Prevalence, consequence, and significance of reverse cleavage by human embryos viewed with the use of the Embryoscope time-lapse video system. Liu Y; Chapple V; Roberts P; Matson P Fertil Steril; 2014 Nov; 102(5):1295-1300.e2. PubMed ID: 25225070 [TBL] [Abstract][Full Text] [Related]
29. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates. Acevedo B; Gomez-Palomares JL; Ricciarelli E; Hernández ER Fertil Steril; 2006 Dec; 86(6):1682-7. PubMed ID: 17074344 [TBL] [Abstract][Full Text] [Related]
30. International Committee for Monitoring Assisted Reproductive Technologies world report: Assisted Reproductive Technology 2006. Mansour R; Ishihara O; Adamson GD; Dyer S; de Mouzon J; Nygren KG; Sullivan E; Zegers-Hochschild F Hum Reprod; 2014 Jul; 29(7):1536-51. PubMed ID: 24795090 [TBL] [Abstract][Full Text] [Related]
31. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle]. Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108 [TBL] [Abstract][Full Text] [Related]
32. Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study. Polyzos NP; De Vos M; Corona R; Vloeberghs V; Ortega-Hrepich C; Stoop D; Tournaye H Hum Reprod; 2013 May; 28(5):1254-60. PubMed ID: 23442756 [TBL] [Abstract][Full Text] [Related]
33. Recombinant LH supplementation to a standard GnRH antagonist protocol in women of 35 years or older undergoing IVF/ICSI: a randomized controlled multicentre study. König TE; van der Houwen LE; Overbeek A; Hendriks ML; Beutler-Beemsterboer SN; Kuchenbecker WK; Renckens CN; Bernardus RE; Schats R; Homburg R; Hompes PG; Lambalk CB Hum Reprod; 2013 Oct; 28(10):2804-12. PubMed ID: 23838159 [TBL] [Abstract][Full Text] [Related]
34. The use of morphokinetic as a predictor of implantation. Tejera A; Aparicio-Ruiz B; Meseguer M Minerva Ginecol; 2017 Dec; 69(6):555-567. PubMed ID: 28643503 [TBL] [Abstract][Full Text] [Related]
35. A GnRH agonist and exogenous hormone stimulation protocol has a higher live-birth rate than a natural endogenous hormone protocol for frozen-thawed blastocyst-stage embryo transfer cycles: an analysis of 1391 cycles. Hill MJ; Miller KA; Frattarelli JL Fertil Steril; 2010 Feb; 93(2):416-22. PubMed ID: 19171338 [TBL] [Abstract][Full Text] [Related]
36. A time to look back: analysis of morphokinetic characteristics of human embryo development. Herrero J; Tejera A; Albert C; Vidal C; de los Santos MJ; Meseguer M Fertil Steril; 2013 Dec; 100(6):1602-9.e1-4. PubMed ID: 24083877 [TBL] [Abstract][Full Text] [Related]
37. Selection of high potential embryos using time-lapse imaging: the era of morphokinetics. Herrero J; Meseguer M Fertil Steril; 2013 Mar; 99(4):1030-4. PubMed ID: 23395415 [TBL] [Abstract][Full Text] [Related]
38. [Ovarian stimulation for IVF in France: choice and results according to protocols and gonadotrophin]. Rossin B; Pouly JL; Belaisch-Allart J; de Mouzon J; Gynecol Obstet Fertil; 2009; 37(11-12):864-72. PubMed ID: 19833539 [TBL] [Abstract][Full Text] [Related]
39. Exposure of embryos to oxygen at low concentration in a cleavage stage transfer program: reproductive outcomes in a time-series analysis. Calzi F; Papaleo E; Rabellotti E; Ottolina J; Vailati S; Viganò P; Candiani M Clin Lab; 2012; 58(9-10):997-1003. PubMed ID: 23163116 [TBL] [Abstract][Full Text] [Related]
40. Effects of embryo culture media do not persist after implantation: a histological study in mice. Hemkemeyer SA; Schwarzer C; Boiani M; Ehmcke J; Le Gac S; Schlatt S; Nordhoff V Hum Reprod; 2014 Feb; 29(2):220-33. PubMed ID: 24324026 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]